The latest price target for Inspire Medical Systems (NYSE:INSP) was reported by Leerink Partners on September 10, 2024. The analyst firm set a price target for $197.00 expecting INSP to fall to within 12 months (a possible -7.45% downside). 28 analyst firms have reported ratings in the last year.

The latest analyst rating for Inspire Medical Systems (NYSE:INSP) was provided by Leerink Partners, and Inspire Medical Systems maintained their market perform rating.

The last upgrade for Inspire Medical Systems Inc happened on December 13, 2022 when Goldman Sachs raised their price target to N/A. Goldman Sachs previously had a neutral for Inspire Medical Systems Inc.

The last downgrade for Inspire Medical Systems Inc happened on January 2, 2024 when Stifel changed their price target from N/A to $210 for Inspire Medical Systems Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inspire Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inspire Medical Systems was filed on September 10, 2024 so you should expect the next rating to be made available sometime around September 10, 2025.

While ratings are subjective and will change, the latest Inspire Medical Systems (INSP) rating was a maintained with a price target of $167.00 to $197.00. The current price Inspire Medical Systems (INSP) is trading at is $212.85, which is out of the analyst’s predicted range.